Iambic Therapeutics, an AI-driven biotech firm, experienced a strong market debut on Nasdaq, with shares rising 16% to $18.50 after a $150 million IPO. The company aims to innovate cancer treatment through its proprietary AI systems and has significant backing from notable inves…
AbbVie is nearing its 52-week high, driven by strong sales of SKYRIZI, its psoriasis and Crohn's disease treatment. However, potential risks to its stock price arise from market c…
Pfizer's stock is receiving a BUY rating from analysts, with a price target of $32.36, indicating a potential upside of 15%. The company has shown strong revenue performance and p…
Zymeworks (NASDAQ:ZYME) shares increased nearly 4% in pre-market trading as investors prepared for a crucial FDA decision regarding zanidatamab, expected on August 25, 2026. The F…
Despite a significant increase in Merck's stock price following strong Q2 earnings, an unusual volume of put options has been traded, suggesting investor concerns about potential…
Curium, backed by CapVest Partners, has announced its acquisition of Lantheus, a US-based radiopharmaceutical company, in an all-cash deal valued at nearly $8 billion. The transac…
OSR Health, Inc. has received confirmation from the Nasdaq Stock Market regarding its Shareholder Loyalty Contingent Value Rights (CVR) program. Nasdaq stated that the program wil…
Nvidia's venture arm, NVentures, has acquired 833,325 shares in Generate Biomedicines, valued at approximately $10.4 million. Generate is developing an AI-driven platform for drug…
This article explores the Optimal Prostate Cancer Diet, highlighting how nutrition can influence cancer progression and survivorship. It emphasizes a plant-based, Mediterranean-st…
Ethel Smith, widow of the late Rangers manager Walter Smith, has made a heartfelt donation of £50,000 to the cancer unit at Vale of Leven Hospital, where her husband received trea…
BioNTech SE's stock fell by 8% after the company halted its Phase 2 colorectal cancer vaccine trial due to futility. This decision has also affected other mRNA vaccine stocks, inc…
A recent study highlights that popular anti-aging supplements could hinder cancer treatment, prompting new guidelines for their use among women, especially those undergoing chemot…